hasMolecularFunction
P68681
predicate
Indicates that an entity (typically a gene product or protein) performs or is associated with a specific molecular-level activity or function.
Observed surface forms (4)
| Surface form | Occurrences |
|---|---|
| proteinFunction | 3 |
| hasMolecularFunctionViaPla | 2 |
| molecularFunctionOfProduct | 2 |
| hasCytoplasmicDomainFunction | 1 |
Sample triples (112)
| Subject | Object |
|---|---|
| TAF15 | DNA binding ⓘ |
| TAF15 | transcription coactivator activity ⓘ |
| TAF15 | RNA splicing factor activity ⓘ |
| CDK6 | ATP binding ⓘ |
| CDK6 | protein serine/threonine kinase activity ⓘ |
| CDK6 | cyclin-dependent protein serine/threonine kinase activity ⓘ |
| Gemin3 | ATP-dependent RNA helicase activity ⓘ |
| Gemin3 | RNA binding ⓘ |
| Gemin3 | ATP binding ⓘ |
| CYP2C9 | monooxygenase activity ⓘ |
| CYP2C9 | oxidoreductase activity ⓘ |
| CYP2C19 | monooxygenase activity ⓘ |
| CYP2C19 | oxidoreductase activity ⓘ |
| CD32 | IgG binding ⓘ |
| CD32 | immune receptor activity ⓘ |
| CD3 complex | signal transduction via predicate surface "hasCytoplasmicDomainFunction" ⓘ |
|
vascular endothelial growth factor A
surface form:
Vascular endothelial growth factor A
|
growth factor activity ⓘ |
|
vascular endothelial growth factor A
surface form:
Vascular endothelial growth factor A
|
receptor binding ⓘ |
|
vascular endothelial growth factor A
surface form:
Vascular endothelial growth factor A
|
vascular endothelial growth factor receptor binding ⓘ |
| tumor necrosis factor alpha | cytokine activity ⓘ |
| tumor necrosis factor alpha | receptor binding ⓘ |
| Pgp | ATP-dependent xenobiotic efflux ⓘ |
| Pgp | drug transmembrane transporter activity ⓘ |
| Pgp | ATP binding ⓘ |
| Pgp | ATPase activity coupled to transmembrane movement of substances ⓘ |
| ABC subfamily B | ATP binding ⓘ |
| ABC subfamily B | ATPase activity ⓘ |
| ABC subfamily B | transmembrane transporter activity ⓘ |
| SARS-CoV-2 spike glycoprotein | receptor binding ⓘ |
| SARS-CoV-2 spike glycoprotein | membrane fusion ⓘ |
| SARS-CoV-2 spike glycoprotein | viral entry into host cell ⓘ |
|
ABCG2 gene
surface form:
ABCG2
|
ATP-dependent transmembrane transporter activity ⓘ |
|
ABCG2 gene
surface form:
ABCG2
|
xenobiotic-transporting ATPase activity ⓘ |
|
ABCG2 gene
surface form:
ABCG2
|
drug transmembrane transporter activity ⓘ |
| Nav1.1 sodium channel | voltage-gated sodium channel activity ⓘ |
| Nav1.1 sodium channel | sodium ion transmembrane transporter activity ⓘ |
| adenylyl cyclase | adenylate cyclase activity ⓘ |
| adenylyl cyclase | ATP binding ⓘ |
| somatostatin receptor | somatostatin binding ⓘ |
| somatostatin receptor | G protein–coupled receptor activity ⓘ |
| somatostatin receptor | signal transducer activity ⓘ |
|
GNAI3 gene (for Gαi3 in humans)
surface form:
GNAI3
|
GTP binding ⓘ |
|
GNAI3 gene (for Gαi3 in humans)
surface form:
GNAI3
|
GTPase activity ⓘ |
|
GNAI3 gene (for Gαi3 in humans)
surface form:
GNAI3
|
signal transducer activity ⓘ |
| CD340 | protein tyrosine kinase activity ⓘ |
| CD340 | transmembrane receptor activity ⓘ |
| ERBB3 | receptor activity ⓘ |
| ERBB3 | protein tyrosine kinase activity (impaired intrinsic kinase) ⓘ |
| ERBB3 | neuregulin binding ⓘ |
|
MS4A1 gene
surface form:
MS4A1
|
CD20 receptor activity ⓘ |